Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04668014 · ClinicalTrials.gov registry record
The Characteristics and Role of Mucosal Microbiome After Treatment of Clostridioides Difficile Infection
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 20
- Enrollment target
NCT04668014: Completed study, sponsored by Mayo Clinic.
NCT04668014 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04668014 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This research is being done to study the ability of C. difficile to colonize the colonic mucosa of individuals with no prior history of C. difficile infection.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-09-01 |
| Est. Completion | 2020-12-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04668014
The ClinicalTrials.gov registry entry for NCT04668014 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04668014 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04668014 about?
NCT04668014 is a clinical study titled "The Characteristics and Role of Mucosal Microbiome After Treatment of Clostridioides Difficile Infection". This research is being done to study the ability of C. difficile to colonize the colonic mucosa of individuals with no prior history of C. difficile infection.
What is the current status of trial NCT04668014?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2019-09-01. Estimated completion is 2020-12-23.
Who is sponsoring clinical trial NCT04668014?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.